Billionaire Profile
U
Global Rank
#2146

Image: Publications Office of the European Union | Public domain | via Wikimedia Commons

Ulrike Baro

CEO, Biopharmaceuticals
GERMANY
Real-Time Net Worth
$1.962B
Estimated based on Biopharmaceuticals stock value as of April 21, 2026
+0.11% (24h)
Age
76
Source
Biopharmaceuticals
Industry
Healthcare
Citizenship
GERMANY

Biography

Ulrike Baro, a prominent figure in the biopharmaceutical industry, holds a net worth of $1.9 billion as of March 2024. This wealth stems from her inheritance and continued involvement in the biopharmaceutical sector, specifically through Sartorius AG. Born and residing in Munich, Germany, Baro's career has been marked by strategic investments and a commitment to innovation, shaping her journey from a legacy in pharmaceuticals to a recognized name in the global business landscape. As of March 24, 2026, her real-time net worth is estimated to be $1.7 billion.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/21/2026

Wealth Over Time

In-Depth Profile

Early Life

Ulrike Baro, born on January 1, 1950, is one of three daughters of Horst Sartorius. Her family's involvement in the biopharmaceutical industry provided a foundation for her future career. Her great-grandfather, Florenz Sartorius, founded Sartorius AG in 1870.

Rise to Success

After the death of her father in 1998, Ulrike inherited a stake in the biopharmaceutical firm Sartorius AG. This inheritance became the cornerstone of her wealth. Sartorius AG, which went public in 1990, manufactures pharmaceutical and laboratory equipment, and today has approximately 10,600 employees.

Key Business Strategies

Baro's wealth is primarily derived from her stake in Sartorius AG. The company's focus on pharmaceutical and laboratory equipment has provided a stable source of income.

Philanthropy

Information regarding specific philanthropic initiatives and amounts is not available in the search results.

Career Milestones

1998

Inheritance of Sartorius AG stake

Inherited a stake in Sartorius AG after her father's passing.